SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-16-007979
Filing Date
2016-11-14
Accepted
2016-11-14 17:36:04
Documents
66
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_093016.htm 10-Q 605745
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-1.htm EX-31.1 8650
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-2.htm EX-31.2 8474
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES ex32-1.htm EX-32.1 3812
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES ex32-2.htm EX-32.2 3758
  Complete submission text file 0001387131-16-007979.txt   4360872

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT admp-20160930.xml EX-101.INS 850181
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20160930.xsd EX-101.SCH 46555
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20160930_cal.xml EX-101.CAL 67788
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20160930_def.xml EX-101.DEF 205679
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20160930_lab.xml EX-101.LAB 345349
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20160930_pre.xml EX-101.PRE 289339
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 161996321
SIC: 2834 Pharmaceutical Preparations